US · SMLR
Semler Scientific, Inc.
- Sector
- Healthcare · Medical - Devices
- Headquarters
- Santa Clara, CA 95051
- Website
- semlerscientific.com
Price · as of 2024-12-31
—
Market cap 425.33M
Valuation summary
Four models, one snapshot. Upside is target ÷ current − 1.
| Valuation method | Value, $ | Upside, % |
|---|---|---|
| Artificial Intelligence(AI) | $85.63 | — |
| Intrinsic Value(DCF) | $31.37 | — |
| Graham-Dodd Method(GD) | $60.21 | — |
| Graham Formula(GF) | — | — |
Valuation history
Annual price (USD per share) overlaid with each model's fair value. Y-axis is log scale.
| Year | Price | AI | DCF | Graham-Dodd | Graham Formula |
|---|---|---|---|---|---|
| 2010 | |||||
| 2011 | |||||
| 2012 | $0.00 | $0.00 | |||
| 2013 | $6.19 | $231.81 | $3,070.10 | $0.00 | $0.00 |
| 2014 | $4.89 | $108.24 | $4,701.68 | $0.00 | $0.00 |
| 2015 | $1.53 | $25.51 | $11,361.90 | $0.00 | $0.00 |
| 2016 | $2.90 | $194.31 | $83.81 | $0.00 | $0.00 |
| 2017 | $8.90 | $426.61 | $594.46 | $0.00 | $0.00 |
| 2018 | $41.00 | $91.43 | $2,113.09 | $3.85 | $51.20 |
| 2019 | $52.73 | $113.97 | $5,336.30 | $13.74 | $136.43 |
| 2020 | $107.00 | $117.01 | $916.10 | $15.16 | $53.52 |
| 2021 | $42.50 | $124.53 | $648.43 | $19.56 | $112.32 |
| 2022 | $21.13 | $90.47 | $169.05 | $18.93 | $31.57 |
| 2023 | $30.62 | $107.99 | $200.75 | $25.95 | $83.92 |
| 2024 | $37.19 | $85.63 | $44.24 | $60.21 | $0.00 |
AI valuation
Our deep-learning model estimates Semler Scientific, Inc.'s (SMLR) per-share fair value from quarterly fundamentals, sector trend, and historical valuation patterns.
- AI fair value
- $85.63
- Current price
- —
- AI upside
- —
Methodology and confidence bands appear in the dedicated valuation theory section. The AI score is an estimate, not a recommendation.
Intrinsic value (DCF)
Open DCF calculatorThree textbook valuation models, recomputed daily from the latest financial statements. The DCF uses our Chepakovich model. Graham-Dodd and Graham Formula are conservative reference points.
DCF
$31.37
— upside
Graham-Dodd
$60.21
— upside
Graham Formula
—
— upside
Peer comparison
Same-industry comparables, ranked by market cap.
| Basic Info | Model Valuation | Core Valuation | Profitability | Leverage & Liquidity | Growth | Cash Flow | Dividends | Enterprise Value | Risk | ||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ticker | Company Name | Price | Market Cap | AI Upside | DCF Upside | GD Upside | GF Upside | P/E | P/B | P/S | EV/EBITDA | PEG | P/TBV | Gross Margin | Operating Margin | Net Margin | ROE | ROIC | ROA | Debt/Equity | Interest Coverage | Current Ratio | Quick Ratio | Net Debt/EBITDA | EPS Growth | Sales Growth | FCF Growth | FCF Yield | Op Cash Flow Ratio | Cash ROIC | Dividend Yield | Dividend Payout | Shareholder Yield | EV/EBIT | EV/FCF | EV/Sales | Altman Z-Score |
| SMLR | Semler Scientific, Inc. | $28.74 | 425.33M | +198% | +9% | +109% | — | 6.57 | 1.17 | 4.78 | 11.81 | 6.92 | 16.68 | 91.55% | 37.19% | 72.65% | 27.04% | 15.50% | 25.73% | 0.00 | — | 3.59 | 3.06 | -0.41 | 9506.00% | -1744.00% | 1881.00% | 9.06% | 3.87 | 21.12% | 0.00% | 0.00% | 0.00% | 12.13 | 10.43 | 4.51 | 18.96 |
| DCTH | Delcath Systems, Inc. | $8.68 | 301.33M | +1,239% | — | — | — | 118.48 | 2.88 | — | 59.54 | — | 2.88 | 0.00% | — | — | 3.00% | 2.70% | 2.70% | 0.01 | — | 10.92 | 9.39 | -11.02 | -10756.00% | -10000.00% | -20899.00% | 6.56% | 2.06 | 111.33% | 0.00% | 0.00% | 3.63% | 348.16 | 10.96 | — | 10.54 |
| NPCE | NeuroPace, Inc. | $12.98 | 429.4M | +127% | +57% | — | — | -11.80 | 39.98 | 4.01 | -20.57 | — | 39.98 | 73.94% | -27.12% | -33.97% | -189.35% | -78.53% | -26.83% | 9.15 | -2.46 | 5.37 | 4.33 | -3.61 | -2677.00% | 2214.00% | -815.00% | -5.70% | -1.18 | -66.15% | 0.00% | 0.00% | 0.00% | -15.73 | -18.68 | 4.27 | -4.71 |
| OMI | Owens & Minor, Inc. | $3.35 | 258.83M | +733% | +19% | — | — | -2.12 | 1.36 | 0.07 | 48.40 | -0.28 | -0.72 | 20.74% | -1.94% | -3.39% | -48.70% | -7.35% | -7.44% | 3.79 | -1.44 | 1.08 | 0.39 | 35.40 | 76000.00% | 355.00% | -11251.00% | -8.69% | 0.09 | -2.36% | 0.00% | 0.00% | 0.00% | -13.75 | -42.87 | 0.27 | 2.30 |
| RXST | RxSight, Inc. | $8.34 | 341.24M | +250% | -42% | -76% | — | — | 1.14 | 2.33 | -2.43 | — | 1.14 | 76.60% | -35.84% | -28.96% | 0.00% | -83.88% | 0.00% | 0.04 | -1204.75 | 10.95 | 9.58 | 0.22 | 3380.00% | -389.00% | -1360.00% | -6.17% | -0.59 | -33.66% | 0.00% | — | 1.44% | -2.00 | -4.98 | 0.72 | 3.16 |
| SENS | Senseonics Holdings, Inc. | $6.73 | 274.14M | +269% | +917% | — | — | -5.18 | -24.61 | 18.13 | -5.73 | -38.01 | -23.91 | 2.37% | -333.05% | -349.84% | -817.17% | 267.39% | -65.88% | -3.69 | -8.87 | 2.35 | 2.13 | 0.20 | 1364.00% | 37.00% | -1107.00% | -15.39% | -1.56 | 224.02% | 0.00% | 0.00% | 0.00% | -5.26 | -6.28 | 17.53 | -12.73 |
| SRDX | Surmodics, Inc. | $27.55 | 393.83M | +373% | -41% | -96% | — | -49.05 | 4.76 | 4.49 | 118.28 | -7.60 | 11.17 | 73.81% | -4.48% | -9.15% | -9.67% | -5.14% | -6.34% | 0.28 | -1.59 | 3.96 | 3.09 | -0.61 | 64545.00% | -491.00% | -14271.00% | -0.57% | 0.01 | -2.95% | 0.00% | 0.00% | 0.00% | -99.07 | -172.40 | 4.44 | 7.30 |
| TCMD | Tactile Systems Technolog… | $24.21 | 540.74M | +159% | +100% | -49% | -31% | — | 3.06 | 2.03 | 16.77 | — | 4.51 | 75.17% | 8.89% | 5.79% | 0.00% | 11.72% | 0.00% | 0.07 | 28.21 | 4.03 | 3.11 | -1.88 | 1714.00% | 1247.00% | 599.00% | 6.03% | 1.05 | 26.58% | 0.00% | — | 6.69% | 20.58 | 14.90 | 1.83 | 9.68 |
| TMCI | Treace Medical Concepts, … | $6.25 | 394.83M | +369% | -89% | — | — | -1.78 | 1.20 | 0.49 | -1.64 | -53.40 | 1.56 | 79.81% | -25.46% | -27.74% | -58.94% | -67.77% | -28.95% | 0.16 | -10.18 | 4.31 | 2.95 | -0.08 | 333.00% | 159.00% | -3953.00% | -28.08% | -0.52 | -36.90% | 0.00% | 0.00% | 52.40% | -1.30 | -2.40 | 0.33 | -0.40 |
| TOI | The Oncology Institute, I… | $4.09 | 382.39M | +516% | +1,210% | — | — | -1.01 | 14.97 | 0.14 | -2.36 | — | -2.91 | 13.73% | -15.28% | -16.44% | -174.89% | -70.35% | -27.75% | 34.31 | -8.02 | 2.15 | 1.88 | -1.37 | -2283.00% | 2133.00% | -2582.00% | -56.44% | -0.51 | -35.49% | 0.00% | 0.00% | 23.64% | -2.12 | -4.19 | 0.32 | 0.03 |
About Semler Scientific, Inc.
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
- CEO
- Douglas Murphy-Chutorian
- Employees
- 79
- Beta
- 1.33
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Upside computed as ($31.37 ÷ —) − 1 = — (DCF, example).